NIPH Clinical Trials Search

Basic Information

Recruitment status	Recruiting
Health condition(s) or Problem(s) studied	COVID-19
Date of first enrollment	06/05/2021
Target sample size	200
Countries of recruitment
Study type	Observational
Intervention(s)

Outcome(s)

Primary Outcome	1) Anti-Ig levels in blood 2) T-cell response in peripheral blood 3) Phenotypes of immune cells in peripheral blood
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	>= 20age old
Age maximum	Not applicable
Gender
Include criteria	1) Subjects working at Kyoto University and aged 20 years old or older at informed consent with no major medical history and other medical problems 2) Subjects aged 65 years old or older at informed consent with no major medical history 3) Subjects who have obtained written consent voluntarily to participate in this trial 4) Subjects who are scheduled to receive COVID-19 vaccination
Exclude criteria	1) Subjects who have been administered with drugs that affect the immune system (excluding external preparations) such as immunomodulators (DMARDs, etc.), immunosuppressants, biologics, etc. 2) Subjects who are tested positive for human immunodeficiency virus (HIV), hepatitis C virus (HCV), hepatitis B virus (HBV), or HTLV-1. 3) Subjects who are otherwise ineligible for this study in the principal investigator's or subinvestigator's opinion.